IP in the digital age: a tricky path ahead for pharma companies?

The pharmaceutical industry is becoming increasingly interested in digital health, and serious money is being invested in the technology.

Read More: IP in the digital age: a tricky path ahead for pharma companies?


Download PDF Share Back To Listing
Loading data